Philips Research is developing the IntelliCap for electronically controlled drug delivery. In addition to the potential benefits of this new technology to improve patient therapy, the IntelliCap promises to be a valuable research tool for the development of any new drug that is delivered via the intestinal tract. The challenge for scientists at Philips Research was to find a way of navigating a drug-loaded pill capsule to the site of disease and then releasing a metered amount of drug into the gut at that location.